A systematic analysis of peptide linker length and liposomal polyethylene glycol coating on cellular uptake of peptide-targeted liposomes

ACS Nano

Volumn 7, Issue 4, 2013, Pages 2935-2947

  Stefanick, Jared F ^a   Ashley, Jonathan D ^a   Kiziltepe, Tanyel ^a,b   Bilgicer, Basar ^a,b  

^a University of Notre Dame   (United States)

^b UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

cellular uptake; HER2; ligand targeted liposome; peptide linker; peptide targeted liposome; polyethylene glycol; VLA 4

Indexed keywords

CELLULAR UPTAKE; CONTROLLED STOICHIOMETRY; HER2; LIPOSOMAL NANOPARTICLES; PEGYLATED LIPOSOMES; PEPTIDE LINKERS; SYNTHETIC STRATEGIES; VLA-4;

COATINGS; LIGANDS; LIPOSOMES; NANOPARTICLES; POLYETHYLENE GLYCOLS; STOICHIOMETRY;

PEPTIDES;

BIOMATERIAL; LIPOSOME; MACROGOL DERIVATIVE; NANOCAPSULE; PEPTIDE;

ARTICLE; CHEMISTRY; EXPERIMENTAL NEOPLASM; HUMAN; MATERIALS TESTING; METABOLISM; PARTICLE SIZE; SYNTHESIS; TUMOR CELL LINE; ULTRASTRUCTURE;

CELL LINE, TUMOR; COATED MATERIALS, BIOCOMPATIBLE; HUMANS; LIPOSOMES; MATERIALS TESTING; NANOCAPSULES; NEOPLASMS, EXPERIMENTAL; PARTICLE SIZE; PEPTIDES; POLYETHYLENE GLYCOLS;

EID: 84876557641     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn305663e     Document Type: Article

References (60)

1. Malam, Y.; Loizidou, M.; Seifalian, A. M. Liposomes and Nanoparticles: Nanosized Vehicles for Drug Delivery in Cancer Trends Pharmacol. Sci. 2009, 30, 592-599
2. Allen, T. M.; Cheng, W. W. K.; Hare, J. I.; Laginha, K. M. Pharmacokinetics and Pharmacodynamics of Lipidic Nano-particles in Cancer Anti-Cancer Agents Med. Chem. 2006, 6, 513-523
3. Sapra, P.; Tyagi, P.; Allen, T. M. Ligand-Targeted Liposomes for Cancer Treatment Curr. Drug Delivery 2005, 2, 369-381
4. Immordino, M. L.; Dosio, F.; Cattel, L. Stealth Liposomes: Review of the Basic Science, Rationale, and Clinical Applications, Existing and Potential Int. J. Nanomed. 2006, 1, 297-315
5. Allen, T. Liposomal Drug Formulations-Rationale for Development and What We Can Expect for the Future Drugs 1998, 56, 747-756
6. Nie, S. Understanding and Overcoming Major Barriers in Cancer Nanomedicine Nanomedicine 2010, 5, 523-528
7. Vega, J.; Ke, S.; Fan, Z.; Wallace, S.; Charsangavej, C.; Li, C. Targeting Doxorubicin to Epidermal Growth Factor Receptors by Site-Specific Conjugation of C225 to Poly(l -glutamic acid) through a Polyethylene Glycol Spacer Pharm. Res. 2003, 20, 826-832
8. Sofou, S.; Sgouros, G. Antibody-Targeted Liposomes in Cancer Therapy and Imaging Expert Opin. Drug Delivery 2008, 5, 189-204
9. Dubey, P.; Mishra, V.; Jain, S.; Mahor, S.; Vyas, S. Liposomes Modified with Cyclic RGD Peptide for Tumor Targeting J. Drug Target. 2004, 12, 257-264
10. Torchilin, V. Recent Advances with Liposomes as Pharmaceutical Carriers Nat. Rev. Drug Discovery 2005, 4, 145-160
11. Schally, A. V. New Approaches to the Therapy of Various Tumors Based on Peptide Analogues. Horm. Metab. Res. 2008, 40.
12. Zhao, X.; Li, H.; Lee, R. J. Targeted Drug Delivery via Folate Receptors. Expert Opin. Drug Delivery 2008, 5.
13. Allen, T. Ligand-Targeted Therapeutics in Anticancer Therapy Nat. Rev. Cancer 2002, 2, 750-763
14. Yezhelyev, M. V.; Gao, X.; Xing, Y.; Al-Hajj, A.; Nie, S.; O'Regan, R. M. Emerging Use of Nanoparticles in Diagnosis and Treatment of Breast Cancer Lancet Oncol. 2006, 7, 657-667
15. Sinha, R.; Kim, G. J.; Nie, S.; Shin, D. M. Nanotechnology in Cancer Therapeutics: Bioconjugated Nanoparticles for Drug Delivery Mol. Cancer Ther. 2006, 5, 1909-1917
16. Ferrari, M. Cancer Nanotechnology: Opportunities and Challenges Nat. Rev. Cancer 2005, 5, 161-171
17. Farokhzad, O. C.; Langer, R. Impact of Nanotechnology on Drug Delivery ACS Nano 2009, 3, 16-20
18. Pirollo, K. F.; Chang, E. H. Does a Targeting Ligand Influence Nanoparticle Tumor Localization or Uptake? Curr. Trends Biotechnol. 2008, 26, 552-558
19. Bartlett, D. W.; Su, H.; Hildebrandt, I. J.; Weber, W. A.; Davis, M. E. Impact of Tumor-Specific Targeting on the Biodistribution and Efficacy of siRNA Nanoparticles Measured by Multimodality in Vivo Imaging Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 15549-15554
20. Kirpotin, D. B.; Drummond, D. C.; Shao, Y.; Shalaby, M. R.; Hong, K.; Nielsen, U. B.; Marks, J. D.; Benz, C. C.; Park, J. W. Antibody Targeting of Long-Circulating Lipidic Nanoparticles Does Not Increase Tumor Localization but Does Increase Internalization in Animal Models Cancer Res. 2006, 66, 6732-6740
21. Garanger, E.; Boturyn, D.; Dumy, P. Tumor Targeting with RGD Peptide Ligands-Design of New Molecular Conjugates for Imaging and Therapy of Cancers Anti-Cancer Agents Med. Chem. 2007, 7, 552-558
22. Hilgenbrink, A.; Low, P. Folate Receptor-Mediated Drug Targeting: From Therapeutics to Diagnostics J. Pharm. Sci. 2005, 94, 2135-2146
23. Xu, L.; Pirollo, K.; Tang, W.; Rait, A.; Chang, E. Transferrin-Liposome- Mediated Systemic p53 Gene Therapy in Combination with Radiation Results in Regression of Human Head and Neck Cancer Xenografts Hum. Gene Ther. 1999, 10, 2941-2952
24. Daniels, T. R.; Delgado, T.; Rodriguez, J. A.; Helguera, G.; Penichet, M. L. The Transferrin Receptor Part I: Biology and Targeting with Cytotoxic Antibodies for the Treatment of Cancer Clin. Immunol. 2006, 121, 144-158
25. Allen, T. M.; Hansen, C.; Martin, F.; Redemann, C.; Yauyoung, A. Liposomes Containing Synthetic Lipid Derivatives of Poly(ethylene glycol) Show Prolonged Circulation Half-Lives in Vivo. Biochim. Biophys. Acta 1991, 1066.
26. Kirpotin, D.; Park, J.; Hong, K.; Zalipsky, S.; Li, W.; Carter, P.; Benz, C.; Papahadjopoulos, D. Sterically Stabilized Anti-HER2 Immunoliposomes: Design and Targeting to Human Breast Cancer Cells in Vitro Biochemistry 1997, 36, 66-75
27. Sapra, P.; Allen, T. Ligand-Targeted Liposomal Anticancer Drugs Prog. Lipid Res. 2003, 42, 439-462
28. Gabizon, A.; Horowitz, A. T.; Goren, D.; Tzemach, D.; Shmeeda, H.; Zalipsky, S. In Vivo Fate of Folate-Targeted Polyethylene-Glycol Liposomes in Tumor-Bearing Mice. Clin. Cancer Res. 2003, 9.
29. Yamada, A.; Taniguchi, Y.; Kawano, K.; Honda, T.; Hattori, Y.; Maitani, Y. Design of Folate-Linked Liposomal Doxorubicin to its Antitumor Effect in Mice. Clin. Cancer Res. 2008, 14.
30. Allen, C.; Dos Santos, N.; Gallagher, R.; Chiu, G.; Shu, Y.; Li, W.; Johnstone, S.; Janoff, A.; Mayer, L.; Webb, M. et al. Controlling the Physical Behavior and Biological Performance of Liposome Formulations through Use of Surface Grafted Poly(ethylene glycol) Biosci. Rep. 2002, 22, 225-250
31. Dos Santos, N.; Allen, C.; Doppen, A.; Anantha, M.; Cox, K. A. K.; Gallagher, R. C.; Karlsson, G.; Edwards, K.; Kenner, G.; Samuels, L. et al. Influence of Poly(ethylene glycol) Grafting Density and Polymer Length On Liposomes: Relating Plasma Circulation Lifetimes to Protein Binding Biochim. Biophys. Acta, Biomembr. 2007, 1768, 1367-1377
32. Tirosh, O.; Barenholz, Y.; Katzhendler, J.; Priev, A. Hydration of Polyethylene Glycol-Grafted Liposomes Biophys. J. 1998, 74, 1371-1379
33. Barenholz, Y. Liposome Application: Problems and Prospects Curr. Opin. Colloid Interface Sci. 2001, 6, 66-77
34. Noble, C.; Kirpotin, D.; Hayes, M.; Mamot, C.; Hong, K.; Park, J.; Benz, C.; Marks, J.; Drummond, D. Development of Ligand-Targeted Liposomes for Cancer Therapy Expert Opin. Ther. Targets 2004, 8, 335-353
35. Lee, T.; Lin, C.; Kuo, S.; Chang, D.; Wu, H. Peptide-Mediated Targeting to Tumor Blood Vessels of Lung Cancer for Drug Delivery Cancer Res. 2007, 67, 10958-10965
36. Marty, C.; Meylan, C.; Schott, H.; Ballmer-Hofer, K.; Schwendener, R. A. Enhanced Heparan Sulfate Proteoglycan-Mediated Uptake of Cell-Penetrating Peptide-Modified Liposomes. Cell. Mol. Life Sci. 2004, 61.
37. Torchilin, V. P.; Rammohan, R.; Weissig, V.; Levchenko, T. S. TAT Peptide on the Surface of Liposomes Affords Their Efficient Intracellular Delivery Even at Low Temperature and in the Presence of Metabolic Inhibitors Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 8786-8791
38. Hansen, C.; Kao, G.; Moase, E.; Zalipsky, S.; Allen, T. Attachment of Antibodies to Sterically Stabilized Liposomes-Evaluation, Comparison and Optimization of Coupling Procedures Biochim. Biophys. Acta, Biomembr. 1995, 1239, 133-144
39. Veronese, F. Peptide and Protein PEGylation: A Review of Problems and Solutions Biomaterials 2001, 22, 405-417
40. Pasut, G.; Guiotto, A.; Veronese, F. Protein, Peptide and Nonpeptide Drug PEGylation for Therapeutic Application Expert Opin. Ther. Pat. 2004, 14, 859-894
41. Nobs, L.; Buchegger, F.; Gurny, R.; Allemann, E. Current Methods for Attaching Targeting Ligands to Liposomes and Nanoparticles J. Pharm. Sci. 2004, 93, 1980-1992
42. Slamon, D. J.; Godolphin, W.; Jones, L. A.; Holt, J. A.; Wong, S. G.; Keith, D. E.; Levin, W. J.; Stuart, S. G.; Udove, J.; Ullrich, A.; et al. Studies of the Her-2/neu Proto-Oncogene in Human-Breast and Ovarian-Cancer. Science 1989, 244.
43. Slamon, D. J.; Clark, G. M.; Wong, S. G.; Levin, W. J.; Ullrich, A.; Mcguire, W. L. Human-Breast Cancer-Correlation of Relapse and Survival with Amplification of the Her-2 Neu Oncogene. Science 1987, 235.
44. Lewis, G. D.; Figari, I.; Fendly, B.; Wong, W. L.; Carter, P.; Gorman, C.; Shepard, H. M. Differential Responses of Human Tumor-Cell Lines to Anti-P185(her2) Monoclonal-Antibodies. Cancer Immunol. Immunother. 1993, 37.
45. Arap, W.; Pasqualini, R.; Ruoslahti, E. Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model Science 1998, 279, 377-380
46. Forssen, E.; Willis, M. Ligand-Targeted Liposomes Adv. Drug Delivery Rev. 1998, 29, 249-271
47. Ellerby, H.; Arap, W.; Ellerby, L.; Kain, R.; Andrusiak, R.; Del Rio, G.; Krajewski, S.; Lombardo, C.; Rao, R.; Ruoslahti, E. et al. Anti-cancer Activity of Targeted Pro-Apoptotic Peptides Nat. Med. 1999, 5, 1032-1038
48. Schiffelers, R.; Koning, G.; ten Hagen, T.; Fens, M.; Schraa, A.; Janssen, A.; Kok, R.; Molema, G.; Storm, G. Anti-Tumor Efficacy of Tumor Vasculature-Targeted Liposomal Doxorubicin J. Controlled Release 2003, 91, 115-122
49. Reubi, J. Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy Endocr. Rev. 2003, 24, 389-427
50. Owen, R. M.; Carlson, C. B.; Xu, J. W.; Mowery, P.; Fasella, E.; Kiessling, L. L. Bifunctional Ligands That Target Cells Displaying the Alpha(v)beta(3) Integrin ChemBioChem 2007, 8, 68-82
51. Mammen, M.; Choi, S. K.; Whitesides, G. M. Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors Angew. Chem., Int. Ed. 1998, 37, 2755-2794
52. Berezov, A.; Zhang, H. T.; Greene, M. I.; Murali, R. Disabling ErbB Receptors with Rationally Designed Exocyclic Mimetics of Antibodies: Structure-Function Analysis J. Med. Chem. 2001, 44, 2565-2574
53. Gabizon, A.; Horowitz, A.; Goren, D.; Tzemach, D.; Mandelbaum-Shavit, F.; Qazen, M.; Zalipsky, S. Targeting Folate Receptor with Folate Linked to Extremities of Poly(ethylene glycol)-Grafted Liposomes: in Vitro Studies Bioconjugate Chem. 1999, 10, 289-298
54. Xia, W.; Low, P. S. Folate-Targeted Therapies for Cancer J. Med. Chem. 2010, 53, 6811-6824
55. Lin, K.; Castro, A. Very Late Antigen 4 (VLA4) Antagonists as Anti-inflammatory Agents Curr. Opin. Chem. Biol. 1998, 2, 453-457
56. Singh, J.; Adams, S.; Carter, M.; Cuervo, H.; Lee, W.; Lobb, R.; Pepinsky, R.; Petter, R.; Scott, D. Rational Design of Potent and Selective VLA-4 Inhibitors and Their Utility in the Treatment of Asthma Curr. Top. Med. Chem. 2004, 4, 1497-1507
57. Jackson, D.; Quan, C.; Artis, D.; Rawson, T.; Blackburn, B.; Struble, M.; Fitzgerald, G.; Chan, K.; Mullins, S.; Burnier, J. et al. Potent Alpha 4 Beta 1 Peptide Antagonists as Potential Anti-inflammatory Agents J. Med. Chem. 1997, 40, 3359-3368
58. Kiziltepe, T.; Ashley, J. D.; Stefanick, J. F.; Qi, Y. M.; Alves, N. J.; Handlogten, M. W.; Suckow, M. A.; Navari, R. M.; Bilgicer, B. Rationally Engineered Nanoparticles Target Multiple Myeloma Cells, Overcome Cell-Adhesion-Mediated Drug Resistance, and Show Enhanced Efficacy in Vivo Blood Cancer J. 2012, 2, e64
59. Roco, M. C. The Long View of Nanotechnology Development: The National Nanotechnology Initiative at 10 Years J. Nanopart. Res. 2011, 13, 427-445
60. Olson, F.; Hunt, C. A.; Szoka, F. C.; Vail, W. J.; Papahadjopoulos, D. Preparation of Liposomes of Defined Size Distribution by Extrusion through Polycarbonate Membranes Biochim. Biophys. Acta 1979, 557